Jul 05, 2024

Ask a Cancer Researcher: How does a tumour’s genetics factor into cancer care?

Jun 21, 2023

Ask a Cancer Researcher: What is immunotherapy?

Feb 03, 2021

Standards redefined: What lab accreditation means to OICR Genomics

Feb 03, 2021

Imagining the next 20 years and planning for the next five

Feb 03, 2021

What we learned at the recent OICR-JLABS cell therapy symposium

May 06, 2020

A message from OICR’s President and Scientific Director, Dr. Laszlo Radvanyi

Feb 05, 2020

Unprecedented exploration generates most comprehensive map of cancer genomes charted to date

Oct 09, 2019

Researchers discover a new cancer-driving mutation in the “dark matter” of the cancer genome

Sep 20, 2019

Harnessing the time before a patient’s surgery to accelerate cancer research

Jul 03, 2019

Five fellows, four labs, three years, two countries, and a generous donation

Dec 10, 2018

A holiday message from the President and Scientific Director

Oct 23, 2018

Updates and highlights from Global Alliance’s 6th Plenary Meeting

Jun 14, 2018

New OICR President and Scientific Director comments on breakthrough in breast cancer T-cell immunotherapy

May 01, 2018

Ontario Institute for Cancer Research welcomes new President and Scientific Director, Dr. Laszlo Radvanyi

Mar 28, 2018

OICR names Dr. Laszlo Radvanyi as new President and Scientific Director